SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001126234-21-000021
Filing Date
2021-02-16
Accepted
2021-02-16 16:34:34
Documents
3
Period of Report
2021-02-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lumo-20210216x8k.htm 8-K 28371
2 EX-99.1 lumo-20210216x8kxex991.htm EX-99.1 14962
3 GRAPHIC image_01.jpg GRAPHIC 2692
  Complete submission text file 0001126234-21-000021.txt   48547
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35342 | Film No.: 21639456
SIC: 2834 Pharmaceutical Preparations